Peter Selin - Kancera AB Exec Devel
| KAN Stock | SEK 1.52 0.09 6.29% |
Insider
Peter Selin is Exec Devel of Kancera AB
| Age | 50 |
| Phone | 46 8 50 12 60 80 |
| Web | https://www.kancera.com |
Kancera AB Management Efficiency
The company has return on total asset (ROA) of (0.2736) % which means that it has lost $0.2736 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4732) %, meaning that it generated substantial loss on money invested by shareholders. Kancera AB's management efficiency ratios could be used to measure how well Kancera AB manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 4 records | INSIDER Age | ||
| Mathias Skalmstad | Sprint Bioscience AB | N/A | |
| Fredrik Carling | Veg of Lund | 52 | |
| Eva Tornberg | Veg of Lund | 75 | |
| Prof MBA | Sprint Bioscience AB | 64 | |
Management Performance
| Return On Equity | -0.47 | |||
| Return On Asset | -0.27 |
Kancera AB Leadership Team
Elected by the shareholders, the Kancera AB's board of directors comprises two types of representatives: Kancera AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kancera. The board's role is to monitor Kancera AB's management team and ensure that shareholders' interests are well served. Kancera AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kancera AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Olin, CEO Director | ||
| Martin Norin, Chief Officer | ||
| Hans Richter, Chief Officer | ||
| Peter Selin, Exec Devel | ||
| Niclas Brynne, Head Devel | ||
| Torbjrn Lundstrm, Chief Officer |
Kancera Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kancera AB a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.47 | |||
| Return On Asset | -0.27 | |||
| Operating Margin | (72.39) % | |||
| Current Valuation | 14.76 M | |||
| Shares Outstanding | 79.53 M | |||
| Shares Owned By Insiders | 13.72 % | |||
| Shares Owned By Institutions | 2.86 % | |||
| Price To Earning | (11.64) X | |||
| Price To Book | 1.44 X | |||
| Price To Sales | 168.19 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kancera AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Kancera Stock analysis
When running Kancera AB's price analysis, check to measure Kancera AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kancera AB is operating at the current time. Most of Kancera AB's value examination focuses on studying past and present price action to predict the probability of Kancera AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kancera AB's price. Additionally, you may evaluate how the addition of Kancera AB to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |